MYOG and neoplasm: As expected, the Rabdhomyosarcoma markers Myogenin and Myoglobin were not expressed, further demonstrating the ability of the LMS undifferenitated cells to differentiate in vivo into a sarcoma of the same subtype as the patient tumor (Figure S2A).